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Primary ciliary dyskinesia (PCD) is an autosomal recessive dis-
ease caused by mutations that affect the proper function of
cilia. Recently, deletion of DNA polymerase  (Poll ) in mice
produced a phenotype characteristic of PCD (Kobayashi et al.,
2002, Mol. Cell. Biol. 22:2769–2776). Because it is unclear how
a mutation in a DNA polymerase would result in a specific de-
fect in axonemes, the targeting construct was examined fur-
ther. Analysis of the genomic region surrounding the Poll gene
revealed an uncharacterized gene, named Dpcd, that is pre-
dicted to be transcribed from the opposite strand relative to
Poll. The deletion of Poll would also remove the first exon of
Dpcd. Because it is possible that the PCD phenotype observed
is due to the absence of either gene, the expression of these
genes during ciliogenesis of human airway epithelial cells was
examined. Northern analysis demonstrated that DPCD expres-
sion increases during ciliated cell differentiation; the expression
of POLL decreases. To examine directly whether DPCD is mu-
tated in cases of human PCD, the complete coding sequence
of DPCD was sequenced from 51 unrelated PCD patients. No
disease-causing mutations were confirmed; however, one vari-
ant could not be excluded. Therefore, DPCD remains a novel
candidate gene for PCD.
Primary ciliary dyskinesia (PCD) is a genotypically hetero-
geneous disease, usually inherited as an autosomal recessive
trait, caused by mutations that impair the function of cilia
and flagella (1–3). The defect in ciliary function in the respi-
ratory tract results in impaired or absent mucociliary clear-
ance, which is believed to be responsible for the frequent
and recurrent episodes of sinusitis and bronchitis that are
typical of this disease. The phenotype of the disease is also
variable; in severe cases patients develop end-stage bronchi-
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ectasis and require lung transplantation. In addition, the
disease affects other organs and processes that require cili-
ary or flagellar motion, and patients with PCD may exhibit
otitis media, situs inverses totalis, and/or infertility.
The respiratory cilium is a complex structure consisting
of  250 proteins (4, 5). In addition to the highly conserved
92 arrangement of microtubule doublets that form the
basic axonemal structure, cilia contain inner and outer dy-
nein arms (IDA, ODA) that provide the force for ciliary
beating. Cilia also contain an unknown number of other
proteins that may be involved in the assembly, maintenance,
and regulation of ciliary function. In theory, a mutation in
many of these genes would lead to the same phenotype, that
is, impaired mucociliary clearance. However, most patients
with PCD exhibit a structural defect in the outer and/or
inner dynein arms. In a small percentage of patients with
PCD, mutations have been identified in an ODA intermedi-
ate chain (DNAI1) (6–9) or an ODA heavy chain (DNAH5)
(10, 11). These results confirm that PCD is a genetically
heterogeneous disease and indicate that the causative muta-
tion in many cases has yet to be identified.
Recently, a deletion of DNA polymerase  (Poll) in mice
was reported to produce a PCD phenotype that included a
lack of inner dynein arms (12). This model exhibited many
of the features associated with other models of PCD, includ-
ing chronic sinusitis, situs inversus totalis, infertility, and
hydrocephalus. Thus, POLL became a candidate gene for
cases of human PCD. Because it is difficult to reconcile the
function of a nuclear DNA polymerase with a specific defect
in axonemal structure (missing IDA), we examined the
deletion construct in more detail and determined that the
expression of another gene was also likely disrupted in the
mouse model. This novel gene, which we have named Dpcd
(for deleted in a mouse model of primary ciliary dyskinesia),
is predicted to code for a protein of 23 kD of unknown
function. In addition, deletion of only the catalytic domain
of pol  in a separate study resulted in mice with a normal
phenotype (13). Thus the PCD phenotype observed in the
Poll knockout mice reported by Kobayashi and coworkers
(12) is most likely due to the loss of Dpcd.
To investigate the possible role of DPCD in human cases
of PCD, the expression of DPCD was examined in a panel
of human tissues to determine if the gene was expressed in
a specific pattern consistent with the PCD phenotype. The
expression of DPCD and POLL were also examined dur-
ing ciliogenesis of human bronchial epithelial (HBE) cells
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in vitro. Finally, to examine whether mutations in DPCD
or POLL could account for some cases of human PCD, we
have sequenced the coding regions of both DPCD and
POLL in a cohort of well-characterized PCD patients. A
preliminary report of this work has been presented (14).
Materials and Methods
Database Analysis
The Dpcd gene was found in the Celera Discovery System mouse
genomic database by searching the region surrounding Poll. Subse-
quent analysis identified the same gene in the National Center for
Biotechnology (NCBI) databases (http://www.ncbi.nlm.nih.gov).
Ensembl (http://www.ensembl.org) was used to visualize the gene
relative to Poll on the chromosomes of mouse and human.
Analysis of DPCD and POLL Expression
RT-PCR primers were designed to amplify probes for DPCD
(458 bp) and POLL (251 bp) based on sequences present in NCBI
(XM_058358* and NM_013274). Primers for DPCD were 5
GTTCACTATTTATTCCCAGACGGC 3 and 5 CACCACAA
CCTCCTTTGGCTT 3; primers for POLL were 5 CCTAGG
AGGGAAGAGGGAGA 3 and 5 TGACTTCACCAGCTGA
GCAC 3. The coding region of DPCD (687 nt) was amplified
using primers 5 TGCTTAGCAGGGGAAAGATG 3 and 5
GCCAAGCCTTGAAGTCTCAC 3, cloned into TopoTA (In-
Vitrogen, Carlsbad, CA) and sequenced (deposited in GenBank
as accession number AY532267). Human multiple tissue northern
blots were purchased from Clontech (Palo Alto, CA) and probed
for DPCD expression according to the manufacturer’s instructions.
For analysis of expression during ciliogenesis, human bronchial
epithelial cells (obtained under protocols approved by the Univer-
sity of North Carolina Institutional Review Board) were cultured
using conditions described in detail elsewhere (15, 16). Total RNA
was harvested from cells grown on plastic for 5 d, cells grown
on collagen-coated Millicell-CM culture inserts (Millipore Corp.,
Bedford, MA) submerged in media for 3 d, and cells cultured on
inserts at an air–liquid interface and harvested on Days 7, 29, and
40 of culture. RNA was isolated using RNeasy reagents (Qiagen
Inc., Valencia, CA), fractionated on an agarose/formaldehyde gel
as previously described (17), transferred to Hybond-N mem-
brane (Amersham Biosciences, Piscataway, NJ), and hybridized
with radioactively labeled probes in Rapid-hyb buffer (Amersham
Biosciences) according to the manufacturer.
Clinical Evaluation and Ciliary Dynein Arm Evaluation
of Patients with PCD
This study was approved by the committee for the protection of
the rights of human subjects at the University of North Carolina
(UNC)-Chapel Hill. The majority of the PCD families (n  44)
were seen and evaluated at General Clinical Research Center at
UNC, whereas 7 families were evaluated at other institutions.
Clinical evaluations, ciliary ultrastructural analysis, and genomic
DNA isolations were performed as described earlier (6). Patients
were categorized as outer dynein arm defects (ODA), inner dyn-
ein arm defects (IDA), both dynein arm defects (Both), and
normal dynein arm (other). A cohort of 68 patients belonging to
51 independent families was selected. There was known consan-
* This sequence record has been removed from the NCBI database (note
added in proof).
guinity in three families. Ages ranged from 10 mo to 73 yr, and
there were 30 males and 38 females. Of the 68 PCD patients, 28
(41%) presented with situs inversus and 1 patient presented with
situs ambiguous. We selected one patient with PCD from each of
the 51 families for the DPCD gene analysis, and 15 patients with
PCD from 15 PCD families for the POLL gene analysis, focusing
on patients with a defect in the IDA.
Mutation Profiling
DNA was extracted from either fresh blood or buccal brushings
using standard procedures. All the coding exons of DPCD (exons
1–6) and POLL (exons 2–9) and the intron/exon boundries were
amplified. All the primer sets were located in the flanking intronic
sequences and are available upon request. Amplifications were
performed using reagents and AmpliTaq polymerase from Perkin
Elmer (Foster City, CA). The initial denaturation was 94C for 5
min, followed by 35 cycles (94C for 30 s, 60C for 30 s, 72C for
45 s) and final extension for 10 min at 72C. Direct DNA sequencing
of PCR products was performed on an ABI310 or ABI3100 auto-
mated DNA sequencer (PE Biosystem, Foster City, CA), using
Prism BigDye primer Cycle Sequencing Ready Reaction kit (PE
Biosystem). Intragenic polymorphisms of DPCD were used for
exclusion mapping. To estimate the frequencies of variants in the
general population, 100–110 chromosomes from non-PCD individ-
uals were analyzed by sequencing.
Results
Analysis of mouse chromosome 19 in the region of the Poll
gene revealed an uncharacterized gene (mCG127478 in the
Celera mouse genomic database) predicted to be tran-
scribed from the opposite strand relative to Poll. The pre-
dicted first exon of this novel gene, named Dpcd, lies only
75 bases from exon 1 of Poll, in the same region encom-
passed by the deletion of Poll reported to produce a PCD
phenotype (12). The 6.4-kb deletion is predicted to remove
the first exon of Dpcd, including the predicted first ATG,
and therefore would likely disrupt the function of both
Dpcd and Poll (Figure 1). Thus the phenotype observed
could be due to the loss of either gene. For comparison,
the deletion reported by Bertocci and colleagues (13) is
also shown. This deletion, which replaced three exons of
pol  with a neo gene, did not produce a PCD phenotype,
suggesting the disruption of Dpcd is likely responsible for
the PCD phenotype.
The human homolog of Dpcd (accession number
XM_058358*; designated DPCD) is located in a highly syn-
tenic region of chromosome 10 (Figure 1). The predicted
human DPCD protein (NP_056263) is 88% identical and
94% similar to the mouse protein. DPCD is predicted to
code for a novel protein of 23 kD with no homology to any
conserved protein domains. Because PCD typically affects
a specific set of axoneme containing tissues, including the
airways and reproductive organs, we examined a panel of
human tissues to determine the pattern of DPCD expres-
sion. Probing northern blots containing samples from 16
different human tissues showed that the highest level of
DPCD expression was in the testis (Figure 2). A single band
close to the expected size of 821 bp was observed, indicating
the absence of any major splice variants. Weak signals were
also observed in RNA from pancreas, skeletal muscle, and
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Figure 1. Diagram showing the chromosomal location
of the DNA polymerase lambda gene (Poll) and the
novel gene Dpcd on mouse chromosome 19. The syn-
tenic region of human chromosome 10 is also shown.
Asterisks indicate the start codons. Targeted deletion
of the region indicated by the green line is predicted to
disrupt both the Poll and Dpcd genes in a mouse model
of PCD (12). Targeted deletion of the region indicated
by the blue line produced animals with a normal pheno-
type (13), suggesting that the PCD phenotype is caused
by disruption of the novel gene, Dpcd.
heart. Other tissues examined showed no detectable expres-
sion, even after prolonged exposure (14 d). The expression
of POLL is also highest in testis, with lower levels of expression
reported in ovary, skeletal muscle, pancreas, and heart (18–
20). Thus the expression pattern of DPCD and POLL follow
a similar pattern when analyzing RNA extracted from total
tissues. However, the absence of a DPCD signal in lung
and other tissues may be due to the low percentage of
Figure 2. Expression of DPCD in human tissues. Northern blots
containing polyadenylated RNA from the indicated human tissues
were probed for DPCD expression. DPCD message was most
abundant in testis, with low levels of expression observed in pan-
creas, skeletal muscle, and heart. Exposure time for the figure
shown was 14 d. Molecular size markers are indicated.
ciliated cells in these total tissue samples. To determine if
DPCD was expressed in airway epithelial cells, RT-PCR
was used to amplify a full-length cDNA from cultured HBE
cells. The sequence of the cDNA was identical to that in the
database, verifying the expression of the predicted transcript
(not shown). To evaluate more specifically whether DPCD
and/or POLL are expressed in ciliated airway epithelial cells
and whether their expression correlated with ciliogenesis,
HBE cells were grown at an air–liquid interface (15, 16).
RNA was isolated from parallel cultures at different stages
of differentiation and analyzed by Northern blotting. At early
time points in these cultures, the HBE cells are undifferenti-
ated and resemble basal cells. With time, the cells differenti-
ate to form a heavily ciliated epithelium similar to that ob-
served in vivo. The expression of ciliated cell–specific genes
has previously been shown to correlate with the development
of ciliated cells in this model system (e.g., Figure 5 in Ref.
21). The results demonstrate that DPCD is expressed in
airway cultures and that it becomes more abundant during
ciliated cell differentiation, consistent with a potential role
in cilia structure or function (Figure 3, top panel). Reprobing
of the blot with a POLL-specific probe showed a low level
of expression early in culture, which appeared to decrease
as differentiation occurred (Figure 3, middle panel).
To examine whether mutations in DPCD could account
for some cases of human PCD, the coding region was se-
quenced from a group of 68 patients with well-characterized
PCD. Initially, we sequenced the coding region of DPCD
from 51 unrelated patients with PCD. During the course
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Figure 3. Expression of DPCD and
POLL RNA during ciliogenesis of
HBE cells. RNA was isolated from
cultures of HBE cells cultured on
plastic for 5 d or at an air–liquid inter-
face for the times indicated. North-
ern analysis was performed using
probes specific for the novel gene
DPCD (top panel) or DNA polymer-
ase lambda (POLL) (middle panel).
The ethidium bromide stained gel
showing the amount of RNA loaded
is shown (bottom panel). The expres-
sion of DPCD increases at later time
points when ciliated cell differentia-
tion is occurring, whereas the expres-
sion of POLL appears to decrease
during differentiation.
of sequence analysis, six sequence variants were detected
(Table 1).
To determine if any of these variants could be patho-
genic, a population study was performed in individuals with-
out PCD (Table 2). Four of these variants were found to
be present in individuals without PCD, with varying fre-
quencies. Five non-PCD individuals were homozygous for
467TC, demonstrating that this variant is clearly not
pathogenic. IVS259AG and 399CT (N133N) variants
were not detected in a homozygous state in the control
population; however, given their high minor allele frequen-
cies (30% and 22%, respectively), they are most likely poly-
morphisms. Also, the 399CT and IVS259AG variants
were found to be in a homozygous state in the unaffected
sibling of PCD1 (Figure E1 in the online supplement). The
unaffected father of PCD151 was also homozygous for the
399CT variant. IVS2–22_40 del had a minor allele fre-
quency of only 1% in the normal population, but this variant
was not detected in an affected sibling of PCD163 (Figure
E1 in the online supplement). Therefore, this variant is
most likely a rare polymorphism. IVS5–48_50 del was not
found in the 106 alleles analyzed from the disease-free indi-
viduals. However, it also is probably a rare polymorphism
because it was detected in one allele from an affected sibling
of PCD354, who was wild-type at this locus (Figure E1 in the
online supplement). The 168TG (S56R) variant was not
detected in 100 alleles analyzed from the control population.
The role of this variant is less certain because it was detected
in a heterozygous state in only one affected individual
(PCD222), who was wild-type for all the other coding nucle-
otides and intron–exon junctions in this gene. It is possible
that a mutation in the noncoding region of the other allele
of DPCD may be responsible for PCD in this individual.
Further studies will be required to test this hypothesis.
The discovery of intragenic polymorphisms was useful
for carrying out exclusion mapping analysis to exclude the
DPCD gene from linkage to PCD, assuming an autosomal
recessive mode of inheritance. For PCD1, affected and un-
affected siblings shared the same genotype at the polymor-
phic loci in intron 2 (IVS259AG) and in exon 4
(399CT), and both the parents were heterozygous. Thus
DPCD was excluded from linkage to PCD in this family.
PCD373 was borne of consanguineous union and was het-
erozygous for IVS259AG; therefore, linkage was also
excluded in this family (Figure E1 in the online supple-
ment). For PCD Patients 10, 16, 34, 108, 163, and 354, the
affected and unaffected siblings were discordant for either
one or more polymorphic loci, hence these families were
also excluded. Given the proximity of the POLL gene to
DPCD gene, all the above-mentioned families are probably
excluded for POLL gene as well.
Because the ultrastructural analysis of the Poll knockout
mouse revealed an absence of IDA (12), we sequenced the
coding region of the POLL gene in a patient from all 13
PCD families with solely an IDA defect, and in two patients
with PCD with normal dynein arms. During the course of
sequence analysis, eight sequence variants were detected
(Table E1 in the online supplement); all of these have been
identified as intragenic polymorphisms (Table E2 in the
online supplement).
Discussion
Although a small number of mutations have recently been
identified as causes of PCD, in the majority of cases the
underlying mutation is still unknown. Recently, a deletion
of DNA polymerase  was reported to produce a PCD
phenotype in a mouse model (12). The COOH terminal
region of DNA polymerase  (pol ) shows 33% sequence
identity with DNA polymerase , and recombinant pol 
displays DNA polymerase activity (19, 20). In addition,
a pol -GFP fusion protein has been shown to localize
predominantly to the nucleus (20). Because it is difficult to
reconcile the function of a nuclear DNA polymerase with
a defect in axonemal structure (missing IDA), we examined
the deletion construct in more detail and determined that
another gene was also likely disrupted in the mouse model.
Other reports have also documented the disruption of more
than one gene in mouse models (22, 23). Therefore, the
results from any genetically modified animal should be in-
terpreted with caution, especially if the phenotype observed
does not agree with the known function of the targeted gene.
Interestingly, an independent deletion of Poll targeting the
catalytic domain produced mice with a normal phenotype
(13). This deletion would not be predicted to disrupt the
coding sequence of the novel gene. Thus the PCD pheno-
type is most likely due to disruption of the novel gene.
The novel gene, which we have named Dpcd, is predicted
to code for a protein of 23 kD of unknown function.
Searches of databases as well as protein analysis programs
have not revealed any significant homology to known pro-
teins or any conserved functional domains to date. The
predicted protein contains several potential phosphoryla-
tion sites and potential amidation and glycosylation sites,
but further studies of the location and function of this novel
protein are clearly required.
Because PCD is caused by an inherited defect in the
structure or function of cilia, a candidate gene would most
likely be expressed in tissues that contain cilia or flagella.
DPCD and POLL are expressed at high relative levels in
the testis, which is consistent with a possible role in the
proper function of cilia and flagella. Both DPCD and POLL
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TABLE 1
A summary of DPCD sequence analysis in patients with PCD
IVS259 IVS2– (S56R) (N133N) (L156S) IVS5–48_50
PCD No. Ultrastructure AG 22_40del 168TG 399CT 467TC delGAG
PCD 1 IDA GG WT/WT TT TT CC WT/WT
*PCD 10 IDA AA WT/WT TT CC TC WT/WT
*PCD 16 Both AG WT/WT TT CT TC WT/WT
PCD 26 Unknown AG WT/WT TT CC TT WT/WT
*PCD 34 Unknown AA WT/WT TT CC TC WT/WT
PCD 62 Both AA WT/WT TT CC TT WT/WT
PCD 66 IDA AA WT/WT TT CC TT WT/d
†PCD 71 Both AA WT/WT TT CC TT WT/WT
PCD 78 Other AA WT/WT TT CC TT WT/WT
PCD 79 IDA AG WT/WT TT CC TC WT/WT
*PCD 108 Other AG WT/WT TT CC TT WT/WT
PCD 116 IDA AA WT/WT TT CC TT WT/WT
PCD 140 Unknown AA WT/WT TT CC TT WT/WT
PCD 151 IDA AG WT/WT TT CT TC WT/WT
PCD 157 Other GG WT/WT TT TT CC WT/WT
PCD 158 Both AG WT/WT TT CT TC WT/WT
*PCD 163 Other AA WT/d TT CC TT WT/WT
PCD 182 Both AG WT/WT TT CC TT WT/WT
PCD 190 IDA AG WT/WT TT CT TC WT/WT
PCD 204 Both AG WT/WT TT CT TC WT/WT
PCD 221 Both AA WT/WT TT CC TT WT/WT
PCD 222 Both AA WT/WT TG CC TT WT/WT
PCD 224 Both AA WT/WT TT CC TT WT/WT
PCD 227 Both AA WT/WT TT CC TC WT/WT
PCD 254 IDA AG WT/WT TT CT TC WT/d
PCD 255 IDA AA WT/WT TT CC TT WT/d
PCD 256 Unknown AG WT/WT TT CT TC WT/WT
PCD 261 IDA GG WT/WT TT CT TC WT/WT
PCD 262 Both AA WT/WT TT CC TT WT/d
PCD 264 Other AA WT/WT TT CC TT WT/d
PCD 274 Unknown GG WT/WT TT CT TC WT/WT
PCD 290 Both AG WT/WT TT CC TT WT/WT
†PCD 299 Both AA WT/WT TT CC TT WT/WT
PCD 306 Other GG WT/WT TT TT CC WT/WT
PCD 333 ODA AA WT/WT TT CC TT WT/WT
PCD 340 Both GG WT/WT TT CC TT WT/WT
PCD 345 Other AG WT/WT TT CT TC WT/WT
*PCD 354 Other AG WT/WT TT CT TC WT/WT
PCD 365 Other AG WT/WT TT CT CC WT/WT
PCD 367 Other AG WT/WT TT CC TC WT/WT
PCD 372 Both AA WT/WT TT CC TT WT/WT
*†PCD 373 Both AG WT/WT TT CC TT WT/WT
PCD 383 Other AA WT/WT TT CC TT WT/d
PCD 388 IDA AA WT/WT TT CC TC WT/WT
PCD 429 IDA AA WT/WT TT CC TT WT/WT
PCD 460 Unknown AG WT/WT TT CT TC WT/WT
PCD 467 Both GG WT/WT TT TT CC WT/WT
PCD 481 Both AA WT/WT TT CC TT WT/WT
PCD 483 Both AA WT/WT TT CC TT WT/WT
PCD 515 IDA AG WT/WT TT CT TC WT/WT
PCD 526 Both AA WT/WT TT CC TT WT/WT
Definition of abbreviations: d, deletion polymorphism; IDA, inner dynein arm defect; ODA, outer dynein arm defect; Both, inner  outer dynein arm defect;
Other, dynein arms normal; WT, wild-type.
Sequence analysis of the DPCD gene. DNA was isolated from a group of PCD patients using standard procedures and the coding region of the DPCD gene,
including intron-exon boundaries, was sequenced.





Population frequency of DPCD variants in PCD and non-PCD individuals
Subject Frequency of Frequency of
Polymorphisms Population Analyzed Wild-type Heterozygous Homozygous Allele 1 Allele 2
IVS259AG Control 51 20 31 0 0.696 0.304
[Intron 2] PCD 51 25 19 7 0.676 0.323
IVS2–22_40del Control 50 49 1 0 0.990 0.010
[Intron 2] PCD 51 50 1 0 0.990 0.010
168TG (S56R) Control 50 50 0 0 1 0
[Exon3] PCD 51 50 1 0 0.990 0.010
399CT (N133N) Control 52 29 23 0 0.780 0.220
[Exon4] PCD 51 33 14 4 0.784 0.216
467TC (L156S) Control 55 22 28 5 0.655 0.345
[Exon5] PCD 51 27 19 5 0.716 0.284
IVS5–48_50del Control 53 53 0 0 1 0
GAG (Intron 5) PCD 51 45 6 0 0.941 0.059
Single nucleotide polymorphism consortium: http://snp.cshl.org/.399CT (N133N): rs7874, 1,488 chromosomes analyzed. C allele: 0.944. T allele: 0.056. 467TC
(L156S): rs7006, 308 chromosomes analyzed. T allele: 0.828; C allele: 0.172.
are expressed at low levels in a wide variety of other tissues,
based on this and previous studies and EST data (18–20).
However, in cultures of normal HBE cells undergoing
ciliogenesis, DPCD increases in a pattern consistent with
other cilia-specific genes (21, 24), whereas the expression
of POLL remains constant or decreases. These data suggest
that DPCD plays a role in the formation or function of
ciliated cells.
Because the above data suggest that DPCD may be
responsible for some cases of PCD, we examined a group
of PCD patients for mutations in DPCD. Thirteen of these
patients had a defect in the IDA, which is the same ciliary
abnormality observed in the mouse model, and 20 patients
had defects in both the IDA and ODA. Six sequence vari-
ants were identified, but none were confirmed as disease
causing. Although several PCD patients were homozygous
for the IVS259AG and 399CT variants, based on ex-
clusion analysis, these are most likely polymorphisms and
not disease causing. In addition, RT-PCR was performed on
three patients (PCD 1, 157, and 158) and yielded a product
of normal size with no mutations detected (not shown).
Although no causative mutations were positively identi-
fied in DPCD, one variant, 168TG, which results in a serine
to arginine change, cannot be eliminated without further
studies. It is possible that in this patient a mutation in the
other DPCD allele may have occurred outside the region
sequenced. For example, a mutation in the promoter region
may prevent expression of the wild-type allele, creating a
DPCD null phenotype.
The fact that no disease causing mutations were identi-
fied in DPCD is not unexpected. PCD is known to be a
heterogeneous disease, and only small numbers of samples
are available for analysis. Further, mutations that cause
PCD in mouse models may be different than those responsi-
ble for human disease. It is interesting to note that hydro-
cephalus is a common feature of many animal models of
PCD, but is uncommon in the human disease. It is possible
that mutations in genes like DPCD may not be compatible
with life, and so may not be found in the PCD population.
A subset of the patients with PCD, including thirteen
with only an IDA defect, were also examined for possible
mutations in the POLL gene. No mutations were detected
in the coding region or splice junctions. A recently reported
study also failed to identify mutations in the POLL gene
in patients with PCD (25). This is perhaps not surprising,
as it appears unlikely that the PCD phenotype observed by
Kobayashi and coworkers (12) was caused by the disruption
of the Poll gene.
In conclusion, our results strongly suggest that the dele-
tion of Dpcd may be responsible for the PCD like phenotype
in the mouse model previously reported. This conclusion
is supported by the expression pattern of Dpcd, the absence
of a known function of a DNA polymerase in the structure/
function of cilia, and by the lack of a PCD phenotype in
mice in which the catalytic region of Poll was specifically
deleted. Our results also show that mutations in the coding
region and splice junctions of DPCD do not account for a
large percentage of PCD cases, although it is possible that
isolated cases may still be found. Further studies are needed
to identify the role of DPCD in cilia structure and function.
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